Thrombolysis for massive pulmonary embolisms in morbid obesity: a multisite case-control study

Chinthaka B Samaranayake; Gregory Keir; Colm McCabe; James Anderson; Khoa Tran; John W Upham

doi:10.1183/23120541.00762-2020

Thrombolysis for massive pulmonary embolisms in morbid obesity: a multisite case-control study

ERJ Open Res. 2021 Mar 1;7(1):00762-2020. doi: 10.1183/23120541.00762-2020. eCollection 2021 Jan.

Authors

Chinthaka B Samaranayake¹, Gregory Keir^{1

2}, Colm McCabe^{3

4}, James Anderson^{5

6}, Khoa Tran^{1

7}, John W Upham^{1

2}

Affiliations

¹ Faculty of Medicine, University of Queensland, Brisbane, Australia.
² Princess Alexandra Hospital, Brisbane, Australia.
³ Royal Brompton & Harefield National Health Service Trust, London, UK.
⁴ National Heart and Lung Institute, Imperial College, London, UK.
⁵ Sunshine Coast University Hospital, Birtinya, Australia.
⁶ School of Medicine, Griffith University, Southport, Australia.
⁷ Logan Hospital, Brisbane, Australia.

Abstract

This case-control study assessed efficacy and safety of systematic thrombolysis in morbidly obese patients with massive pulmonary embolisms. Thrombolysis at conventional doses seems to have similar efficacy and bleeding rates in morbidly obese patients. https://bit.ly/38ZqJr4.